Cancer Targeted Small Molecule Therapy and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Cancer Targeted Small Molecule Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Targeted Small Molecule Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Targeted Small Molecule Therapy Overall Market Size
2.1 Global Cancer Targeted Small Molecule Therapy Market Size: 2022 VS 2029
2.2 Global Cancer Targeted Small Molecule Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Targeted Small Molecule Therapy Players in Global Market
3.2 Top Global Cancer Targeted Small Molecule Therapy Companies Ranked by Revenue
3.3 Global Cancer Targeted Small Molecule Therapy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Targeted Small Molecule Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Targeted Small Molecule Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Targeted Small Molecule Therapy Players in Global Market
3.6.1 List of Global Tier 1 Cancer Targeted Small Molecule Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Targeted Small Molecule Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Targeted Small Molecule Therapy Market Size Markets, 2022 & 2029
4.1.2 Sorafenib
4.1.3 Lenvatinib
4.1.4 Regorafenib
4.1.5 Osimertinib
4.1.6 Anlotinib
4.1.7 Alectinib
4.1.8 Other
4.2 By Type - Global Cancer Targeted Small Molecule Therapy Revenue & Forecasts
4.2.1 By Type - Global Cancer Targeted Small Molecule Therapy Revenue, 2018-2023
4.2.2 By Type - Global Cancer Targeted Small Molecule Therapy Revenue, 2024-2029
4.2.3 By Type - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Targeted Small Molecule Therapy Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Cancer Targeted Small Molecule Therapy Revenue & Forecasts
5.2.1 By Application - Global Cancer Targeted Small Molecule Therapy Revenue, 2018-2023
5.2.2 By Application - Global Cancer Targeted Small Molecule Therapy Revenue, 2024-2029
5.2.3 By Application - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Targeted Small Molecule Therapy Market Size, 2022 & 2029
6.2 By Region - Global Cancer Targeted Small Molecule Therapy Revenue & Forecasts
6.2.1 By Region - Global Cancer Targeted Small Molecule Therapy Revenue, 2018-2023
6.2.2 By Region - Global Cancer Targeted Small Molecule Therapy Revenue, 2024-2029
6.2.3 By Region - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Targeted Small Molecule Therapy Revenue, 2018-2029
6.3.2 US Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.3.3 Canada Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.3.4 Mexico Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Targeted Small Molecule Therapy Revenue, 2018-2029
6.4.2 Germany Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.3 France Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.4 U.K. Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.5 Italy Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.6 Russia Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.8 Benelux Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Targeted Small Molecule Therapy Revenue, 2018-2029
6.5.2 China Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.3 Japan Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.4 South Korea Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.6 India Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Targeted Small Molecule Therapy Revenue, 2018-2029
6.6.2 Brazil Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.6.3 Argentina Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Targeted Small Molecule Therapy Revenue, 2018-2029
6.7.2 Turkey Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.7.3 Israel Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.7.5 UAE Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
7 Cancer Targeted Small Molecule Therapy Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Cancer Targeted Small Molecule Therapy Major Product Offerings
7.1.4 Bayer Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Eisai
7.2.1 Eisai Company Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Cancer Targeted Small Molecule Therapy Major Product Offerings
7.2.4 Eisai Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.2.5 Eisai Key News & Latest Developments
7.3 Zelgen
7.3.1 Zelgen Company Summary
7.3.2 Zelgen Business Overview
7.3.3 Zelgen Cancer Targeted Small Molecule Therapy Major Product Offerings
7.3.4 Zelgen Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.3.5 Zelgen Key News & Latest Developments
7.4 Cipla
7.4.1 Cipla Company Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Cancer Targeted Small Molecule Therapy Major Product Offerings
7.4.4 Cipla Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.4.5 Cipla Key News & Latest Developments
7.5 Natco Pharma
7.5.1 Natco Pharma Company Summary
7.5.2 Natco Pharma Business Overview
7.5.3 Natco Pharma Cancer Targeted Small Molecule Therapy Major Product Offerings
7.5.4 Natco Pharma Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.5.5 Natco Pharma Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Cancer Targeted Small Molecule Therapy Major Product Offerings
7.6.4 AstraZeneca Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Cancer Targeted Small Molecule Therapy Major Product Offerings
7.7.4 Novartis Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Roche
7.8.1 Roche Company Summary
7.8.2 Roche Business Overview
7.8.3 Roche Cancer Targeted Small Molecule Therapy Major Product Offerings
7.8.4 Roche Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.8.5 Roche Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Cancer Targeted Small Molecule Therapy Major Product Offerings
7.9.4 Bristol-Myers Squibb Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Cancer Targeted Small Molecule Therapy Major Product Offerings
7.10.4 Pfizer Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 BEACON Pharma
7.11.1 BEACON Pharma Company Summary
7.11.2 BEACON Pharma Business Overview
7.11.3 BEACON Pharma Cancer Targeted Small Molecule Therapy Major Product Offerings
7.11.4 BEACON Pharma Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.11.5 BEACON Pharma Key News & Latest Developments
7.12 Jiangxi Shanxiang
7.12.1 Jiangxi Shanxiang Company Summary
7.12.2 Jiangxi Shanxiang Business Overview
7.12.3 Jiangxi Shanxiang Cancer Targeted Small Molecule Therapy Major Product Offerings
7.12.4 Jiangxi Shanxiang Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.12.5 Jiangxi Shanxiang Key News & Latest Developments
7.13 Yao Pharma
7.13.1 Yao Pharma Company Summary
7.13.2 Yao Pharma Business Overview
7.13.3 Yao Pharma Cancer Targeted Small Molecule Therapy Major Product Offerings
7.13.4 Yao Pharma Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.13.5 Yao Pharma Key News & Latest Developments
7.14 CSPC
7.14.1 CSPC Company Summary
7.14.2 CSPC Business Overview
7.14.3 CSPC Cancer Targeted Small Molecule Therapy Major Product Offerings
7.14.4 CSPC Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.14.5 CSPC Key News & Latest Developments
7.15 CHIATAI Tianqing
7.15.1 CHIATAI Tianqing Company Summary
7.15.2 CHIATAI Tianqing Business Overview
7.15.3 CHIATAI Tianqing Cancer Targeted Small Molecule Therapy Major Product Offerings
7.15.4 CHIATAI Tianqing Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.15.5 CHIATAI Tianqing Key News & Latest Developments
7.16 Simcere
7.16.1 Simcere Company Summary
7.16.2 Simcere Business Overview
7.16.3 Simcere Cancer Targeted Small Molecule Therapy Major Product Offerings
7.16.4 Simcere Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.16.5 Simcere Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Cancer Targeted Small Molecule Therapy Market Opportunities & Trends in Global Market
Table 2. Cancer Targeted Small Molecule Therapy Market Drivers in Global Market
Table 3. Cancer Targeted Small Molecule Therapy Market Restraints in Global Market
Table 4. Key Players of Cancer Targeted Small Molecule Therapy in Global Market
Table 5. Top Cancer Targeted Small Molecule Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Targeted Small Molecule Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Targeted Small Molecule Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Targeted Small Molecule Therapy Product Type
Table 9. List of Global Tier 1 Cancer Targeted Small Molecule Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Targeted Small Molecule Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Targeted Small Molecule Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Targeted Small Molecule Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Targeted Small Molecule Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Targeted Small Molecule Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Targeted Small Molecule Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Bayer Company Summary
Table 31. Bayer Cancer Targeted Small Molecule Therapy Product Offerings
Table 32. Bayer Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer Key News & Latest Developments
Table 34. Eisai Company Summary
Table 35. Eisai Cancer Targeted Small Molecule Therapy Product Offerings
Table 36. Eisai Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Eisai Key News & Latest Developments
Table 38. Zelgen Company Summary
Table 39. Zelgen Cancer Targeted Small Molecule Therapy Product Offerings
Table 40. Zelgen Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Zelgen Key News & Latest Developments
Table 42. Cipla Company Summary
Table 43. Cipla Cancer Targeted Small Molecule Therapy Product Offerings
Table 44. Cipla Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Cipla Key News & Latest Developments
Table 46. Natco Pharma Company Summary
Table 47. Natco Pharma Cancer Targeted Small Molecule Therapy Product Offerings
Table 48. Natco Pharma Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Natco Pharma Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Cancer Targeted Small Molecule Therapy Product Offerings
Table 52. AstraZeneca Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Cancer Targeted Small Molecule Therapy Product Offerings
Table 56. Novartis Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Roche Company Summary
Table 59. Roche Cancer Targeted Small Molecule Therapy Product Offerings
Table 60. Roche Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Roche Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Summary
Table 63. Bristol-Myers Squibb Cancer Targeted Small Molecule Therapy Product Offerings
Table 64. Bristol-Myers Squibb Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol-Myers Squibb Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Cancer Targeted Small Molecule Therapy Product Offerings
Table 68. Pfizer Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. BEACON Pharma Company Summary
Table 71. BEACON Pharma Cancer Targeted Small Molecule Therapy Product Offerings
Table 72. BEACON Pharma Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. BEACON Pharma Key News & Latest Developments
Table 74. Jiangxi Shanxiang Company Summary
Table 75. Jiangxi Shanxiang Cancer Targeted Small Molecule Therapy Product Offerings
Table 76. Jiangxi Shanxiang Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Jiangxi Shanxiang Key News & Latest Developments
Table 78. Yao Pharma Company Summary
Table 79. Yao Pharma Cancer Targeted Small Molecule Therapy Product Offerings
Table 80. Yao Pharma Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Yao Pharma Key News & Latest Developments
Table 82. CSPC Company Summary
Table 83. CSPC Cancer Targeted Small Molecule Therapy Product Offerings
Table 84. CSPC Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. CSPC Key News & Latest Developments
Table 86. CHIATAI Tianqing Company Summary
Table 87. CHIATAI Tianqing Cancer Targeted Small Molecule Therapy Product Offerings
Table 88. CHIATAI Tianqing Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. CHIATAI Tianqing Key News & Latest Developments
Table 90. Simcere Company Summary
Table 91. Simcere Cancer Targeted Small Molecule Therapy Product Offerings
Table 92. Simcere Cancer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Simcere Key News & Latest Developments
List of Figures
Figure 1. Cancer Targeted Small Molecule Therapy Segment by Type in 2022
Figure 2. Cancer Targeted Small Molecule Therapy Segment by Application in 2022
Figure 3. Global Cancer Targeted Small Molecule Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Targeted Small Molecule Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Targeted Small Molecule Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Targeted Small Molecule Therapy Revenue in 2022
Figure 8. By Type - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 16. US Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 28. China Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Bayer Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eisai Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Zelgen Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cipla Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Natco Pharma Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Roche Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol-Myers Squibb Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Pfizer Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. BEACON Pharma Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Jiangxi Shanxiang Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Yao Pharma Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. CSPC Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. CHIATAI Tianqing Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Simcere Cancer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
